{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:35:54Z","timestamp":1768624554311,"version":"3.49.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Infectious peritonitis is a leading cause of peritoneal functional impairment and a primary factor for therapy discontinuation in peritoneal dialysis (PD) patients. Although bacterial infections are a common cause of peritonitis episodes, emerging evidence suggests a role for viral pathogens. Toll-like receptors (TLRs) specifically recognize conserved pathogen-associated molecular patterns (PAMPs) from bacteria, viruses, and fungi, thereby orchestrating the ensuing inflammatory\/immune responses. Among TLRs, TLR3 recognizes viral dsRNA and triggers antiviral response cascades upon activation. Epigenetic regulation, mediated by histone deacetylase (HDAC), has been demonstrated to control several cellular functions in response to various extracellular stimuli. Employing epigenetic target modulators, such as epidrugs, is a current therapeutic option in several cancers and holds promise in treating viral diseases. This study aims to elucidate the impact of TLR3 stimulation on the plasticity of human mesothelial cells (MCs) in PD patients and to investigate the effects of HDAC1-3 inhibition. Treatment of MCs from PD patients with the TLR3 agonist polyinosinic:polycytidylic acid (Poly(I:C)), led to the acquisition of a bona fide mesothelial-to-mesenchymal transition (MMT) characterized by the upregulation of mesenchymal genes and loss of epithelial-like features. Moreover, Poly(I:C) modulated the expression of several inflammatory cytokines and chemokines. A quantitative proteomic analysis of MCs treated with MS-275, an HDAC1-3 inhibitor, unveiled altered expression of several proteins, including inflammatory cytokines\/chemokines and interferon-stimulated genes (ISGs). Treatment with MS-275 facilitated MMT reversal and inhibited the interferon signature, which was associated with reduced STAT1 phosphorylation. However, the modulation of inflammatory cytokine\/chemokine production was not univocal, as IL-6 and CXCL8 were augmented while TNF-\u03b1 and CXCL10 were decreased. Collectively, our findings underline the significance of viral infections in acquiring a mesenchymal-like phenotype by MCs and the potential consequences of virus-associated peritonitis episodes for PD patients. The observed promotion of MMT reversal and interferon response inhibition by an HDAC1-3 inhibitor, albeit without a general impact on inflammatory cytokine production, has translational implications deserving further analysis.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1308362","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T05:00:43Z","timestamp":1709010043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal\/inflammatory phenotype"],"prefix":"10.3389","volume":"14","author":[{"given":"Flavia","family":"Trionfetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Montaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Caiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Bontempi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Terri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Domenici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cordani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Zwergel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusi","family":"Prencipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ruiz-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","article-title":"Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network","volume":"92","author":"Aufricht","year":"2017","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: Emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41419-022-05398-0","article-title":"Restoration of WT1\/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells","volume":"13","author":"Bontempi","year":"2022","journal-title":"Cell Death Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/onc.2009.306","article-title":"Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation","volume":"29","author":"Borbone","year":"2010","journal-title":"Oncogene"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.0400567101","article-title":"Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity","volume":"101","author":"Chang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1093\/ndt\/gfr217","article-title":"Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors","volume":"26","author":"Colmont","year":"2011","journal-title":"Nephrol. Dial Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2533\/chimia.2022.448","article-title":"Current HDAC inhibitors in clinical trials","volume":"76","author":"Di Bello","year":"2022","journal-title":"Chimia (Aarau)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12876-022-02101-7","article-title":"MS275 as Class I HDAC inhibitor displayed therapeutic potential on Malignant ascites by iTRAQ-based quantitative proteomic analysis","volume":"22","author":"Du","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/156800911794328510","article-title":"Epigenetic regulation of gene expression as an anticancer drug target","volume":"11","author":"Ferguson","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/ijc.25151","article-title":"Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin","volume":"127","author":"Hayashi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13148-010-0003-5","article-title":"Histone deacetylases in viral infections","volume":"1","author":"Herbein","year":"2010","journal-title":"Clin. Epigenet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1038\/s41467-021-25393-x","article-title":"Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape","volume":"12","author":"Hicks","year":"2021","journal-title":"Nat. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/s1074-7613(01)00151-0","article-title":"Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation","volume":"14","author":"Hurst","year":"2001","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"L461","DOI":"10.1152\/ajplung.00276.2007","article-title":"Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of beta-defensin-2 by staphylococcal peptidoglycan","volume":"295","author":"Hussain","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2015.11.010","article-title":"Toll\/IL-1 domain-containing adaptor inducing IFN-beta (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation","volume":"77","author":"Hwang","year":"2016","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1084\/jem.176.4.1165","article-title":"Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells","volume":"176","author":"Jonjic","year":"1992","journal-title":"J. Exp. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101626","article-title":"Targeting histone deacetylases in idiopathic pulmonary fibrosis: A future therapeutic option","volume":"11","author":"Korfei","year":"2022","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/0973-1482.137937","article-title":"Epigenetic therapy of cancer with histone deacetylase inhibitors","volume":"10","author":"Lakshmaiah","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1681\/ASN.2013040332","article-title":"Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients","volume":"24","author":"Lin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/089686080602600103","article-title":"Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure","volume":"26","author":"Lopez-Cabrera","year":"2006","journal-title":"Perit Dial Int."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/2040622319862697","article-title":"HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis","volume":"10","author":"Lyu","year":"2019","journal-title":"Ther. Adv. Chronic Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/epi.10.7","article-title":"Small-molecule chromatin-modifying agents: therapeutic applications","volume":"2","author":"Mai","year":"2010","journal-title":"Epigenomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12079-012-0185-z","article-title":"TLR3 activation evokes IL-6 secretion, autocrine regulation of Stat3 signaling and TLR2 expression in human bronchial epithelial cells","volume":"7","author":"Melkamu","year":"2013","journal-title":"J. Cell Commun. Signal"},{"key":"B26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.matbio.2009.12.002","article-title":"Effect of activation of viral receptors on the gelatinases MMP-2 and MMP-9 in human mesothelial cells","volume":"29","author":"Merkle","year":"2010","journal-title":"Matrix Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jhep.2021.07.003","article-title":"Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response","volume":"75","author":"Montaldo","year":"2021","journal-title":"J. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1002\/pmic.200800866","article-title":"Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors","volume":"9","author":"Naldi","year":"2009","journal-title":"Proteomics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14742","DOI":"10.1073\/pnas.2433987100","article-title":"Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1","volume":"100","author":"Nusinzon","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1159\/000366359","article-title":"Expression and function of RIG-I in oral keratinocytes and fibroblasts","volume":"34","author":"Ohta","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.4155\/fmc-2016-0073","article-title":"MC1568 inhibits HDAC6\/8 activity and influenza A virus replication in lung epithelial cells: role of Hsp90 acetylation","volume":"8","author":"Panella","year":"2016","journal-title":"Future Med. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4049\/jimmunol.179.1.514","article-title":"Nod1\/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells","volume":"179","author":"Park","year":"2007","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1681\/ASN.2015080923","article-title":"Toll-like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis","volume":"28","author":"Raby","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.kint.2018.03.014","article-title":"Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis","volume":"94","author":"Raby","year":"2018","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/cei.13192","article-title":"HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis","volume":"194","author":"Rosler","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1038\/s41598-018-26319-2","article-title":"HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal","volume":"8","author":"Rossi","year":"2018","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","article-title":"A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors","volume":"96","author":"Saito","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213363120","article-title":"Repurposing HDAC inhibitors to enhance ribonuclease 4 and 7 expression and reduce urinary tract infection","volume":"120","author":"Schwartz","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-013-2784-7","article-title":"Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin","volume":"143","author":"Shah","year":"2014","journal-title":"Breast Cancer Res. Treat"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030815","article-title":"Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models","volume":"7","author":"Shen","year":"2012","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3543678","article-title":"Molecular mechanisms underlying peritoneal EMT and fibrosis","volume":"2016","author":"Strippoli","year":"2016","journal-title":"Stem Cells Int."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006996","article-title":"STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor","volume":"13","author":"Sulczewski","year":"2022","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/s1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.607204","article-title":"Mechanisms of peritoneal fibrosis: focus on immune cells-peritoneal stroma interactions","volume":"12","author":"Terri","year":"2021","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1165\/rcmb.2016-0259OC","article-title":"NF-kappaB mediates mesenchymal transition, remodeling, and pulmonary fibrosis in response to chronic inflammation by viral RNA patterns","volume":"56","author":"Tian","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/ki.1993.36","article-title":"Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha","volume":"142","author":"Topley","year":"1993","journal-title":"Am. J. Pathol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.1993.36","article-title":"Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha","volume":"43","author":"Topley","year":"1993","journal-title":"Kidney Int."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1257683","article-title":"HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells","volume":"13","author":"Trionfetti","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065763","article-title":"Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis","volume":"24","author":"Trionfetti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-6-1","article-title":"HDAC inhibitors in experimental liver and kidney fibrosis","volume":"6","author":"Van Beneden","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1160\/th08-11-0744","article-title":"Role of viral receptors TLR3, RIG-I and MDA5 in mesothelial tissue-type plasminogen activator and plasminogen activator inhibitor-1 synthesis","volume":"101","author":"Wornle","year":"2009","journal-title":"Thromb. Haemost."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s12010-009-8643-7","article-title":"Role of toll-like receptor 3, RIG-I, and MDA5 in the expression of mesothelial IL-8 induced by viral RNA","volume":"160","author":"Wornle","year":"2010","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11010-008-9957-4","article-title":"Novel role of toll-like receptor 3, RIG-I and MDA5 in poly (I:C) RNA-induced mesothelial inflammation","volume":"322","author":"Wornle","year":"2009","journal-title":"Mol. Cell Biochem."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03408-22","article-title":"Porcine Epidemic Diarrhea Virus Antagonizes Host IFN-lambda-Mediated Responses by Tilting Transcription Factor STAT1 toward Acetylation over Phosphorylation To Block Its Activation","volume":"14","author":"Xu","year":"2023","journal-title":"mBio"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106356","article-title":"Synergistic induction of CCL5, CXCL9 and CXCL10 by IFN-gamma and NLRs ligands on human fibroblast-like synoviocytes-A potential immunopathological mechanism for joint inflammation in rheumatoid arthritis","volume":"82","author":"Yu","year":"2020","journal-title":"Int. Immunopharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1137332","article-title":"Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1074\/jbc.M109.071274","article-title":"Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation","volume":"285","author":"Zhu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1517\/17460441.2015.1038236","article-title":"Emerging approaches for histone deacetylase inhibitor drug discovery","volume":"10","author":"Zwergel","year":"2015","journal-title":"Expert Opin. Drug Discovery"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1308362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T05:00:49Z","timestamp":1709010049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1308362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":62,"alternative-id":["10.3389\/fcimb.2024.1308362"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1308362","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"article-number":"1308362"}}